Olink

We also want to bring to bear other proteomic techniques.

We haven't touched on this yet, but in this paper we used something called Olink, but there are other proteomic approaches that could be brought to bear, and we want to explore those techniques to see what are the similarities, what are the differences that would help give us confidence in some of the targets.

And then once we really have that short list of proteins that we think are most informative, there's some work that needs to be done to develop perhaps more traditional immunoassays that are really robust and can be used in central laboratories or clinical laboratories that ultimately could get this small set of proteins out into much broader use.

And what are next steps as far as, um, the study goes, and, and where, where do you take it from here?